Does FDA Rejection Of Label Warning Shield Manufacturers From Tort Suits?
Executive Summary
US Supreme Court asks Solicitor General to weigh in on Merck petition requesting clarification of its Wyeth v. Levine ruling; Third Circuit says decision is 'cryptic and open-ended.'
You may also be interested in...
Supreme Court Docket Includes Four Cases Impacting Pharma Industry
Helsinn v. Teva and Merck v. Albrecht directly involve pharma firms while another case addresses America Invents Act. Solicitor General to weigh in on two other cases. Petitions pending on Maryland pricing law, Amgen PCSK9 suit.
Supreme Court Docket Includes Four Cases Impacting Pharma Industry
Helsinn v. Teva and Merck v. Albrecht directly involve pharma firms while another case addresses America Invents Act. Solicitor General to weigh in on two other cases. Petitions pending on Maryland pricing law, Amgen PCSK9 suit.
Judge Kavanaugh May Be Good US Supreme Court Pick For Pharma
Supreme Court nominee may side with biopharma companies in agency disputes, but it's unclear how he will rule on patent and product liability cases scheduled for review next term.